norm: bioxytranUSLEI 549300Q3J615PTZIU425 · no CIKMax severity: Low

Canonical registry

Bioxytran

ent_019e3de19bc97f16507c02a982580130

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Bioxytran
Normalized: bioxytran— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 549300Q3J615PTZIU425
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-04-15
Bioxytran's 10-K Item 1C cybersecurity risk management disclosure describes governance, Board/Audit Committee oversight, CFO-led risk management, and third-party assessments. The filing states the company has not encountered cybersecurity challenges that have materially impaired its operations or financial standing. No incident is disclosed.